TMCnet News
Genisphere and Sidney Kimmel Cancer Center at Jefferson Health Collaborate on the Treatment of Pancreatic CancerHATFIELD, Pa. and PHILADELPHIA, May 30, 2018 /PRNewswire/ -- Genisphere LLC and the Sidney Kimmel Cancer Center at Jefferson Health announced a research collaboration to develop novel approaches to treat pancreatic cancer. According to their Sponsored Research Agreement, investigators at the Sidney Kimmel Cancer Center and Genisphere will combine expertise to optimize 3DNA®-based therapeutics designed to target and kill pancreatic tumors. Projects will include delivering small molecule therapeutics as well as siRNA formulated with pancreatic tumor-targeting molecules on Genisphere's 3DNA® nanocarrier. The Principal Investigator on the project is Jonathan Brody, Ph.D., Co-director of the Jefferson Pancreatic, Biliary and Related Cancer Center and Director of Surgical Research. He said "Unfortunately, to date, our most successful therapies for pancreatic cancer, besides surgery, have been non-targeted chemotherapies. The concept of developing and deploying a nanotechnology-based targeted approach that could be personalized and delivered successfully to our patients is promising and exciting." Charles J. Yeo, the 8th Samuel D. Gross Professor and Chairman, Department of Surgery, stated "We are continuing our most diligent and laser-focused efforts to develop novel therapies to offer patients affected by pancreatic cancer. This tumor has now ascended to become the third leading cause of cancer-related death in America. Using a military analogy, this collaboration can be likened to using highly sophisticated smart bombs to destroy specific targets, minimizing collateral damage." Robert Getts, Genisphere's Chief Science Officer, said "Over the past three years we have generated a growing body of evidence demonstrating the uniqueness of the 3DNA platform while consistently adapting to meet the growing desire to move 3DNA-based therapies into a clinical setting like that of our colleagues at Jefferson. We re thrilled to expand our small drug and siRNA studies to include robust pre-clinical models to examine tumor targeting and accumulation as well as unique combination therapies for patients." About Genisphere For more information contact: About Sidney Kimmel Cancer Center at Jefferson Health For more information contact:
View original content with multimedia:http://www.prnewswire.com/news-releases/genisphere-and-sidney-kimmel-cancer-center-at-jefferson-health-collaborate-on-the-treatment-of-pancreatic-cancer-300656254.html SOURCE Genisphere and SKCC at Jefferson Health |